Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. (Q37863536)

24 August 2017

1 reference

title

Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. (English)

1 reference

24 August 2017

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

Rene-Jean Bensadoun

1

1 reference

24 August 2017

Lauren L Patton

series ordinal

2

1 reference

24 August 2017

Rajesh V Lalla

series ordinal

3

1 reference

24 August 2017

Joel B Epstein

series ordinal

4

1 reference

24 August 2017

10 April 2011

1 reference

Supportive Care in Cancer

24 August 2017

1 reference

24 August 2017

19

1 reference

24 August 2017

6

1 reference

24 August 2017

737-744

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-011-1154-4

24 August 2017

0 references

cites work

Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Oral yeast carriage in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Adjunctive use of chlorhexidine in oral candidoses: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Oral health status of 207 head and neck cancer patients before, during and after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

A systematic review of oral fungal infections in patients receiving cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Management of oral mucositis in patients who have cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Dental decay due to xerostomia and nystatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

The impact of cigarette/tobacco smoking on oral candidosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Cytotoxic drugs, radiotherapy and oral candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Colonization of Candida: prevalence among tongue-pierced and non-pierced immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1154-4

Candida and oral candidosis: a review

21 January 2018

1 reference

12 December 2020

Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy

1 reference

12 December 2020

Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer

1 reference

12 December 2020

New strategies for management of oral mucositis in cancer patients

1 reference

12 December 2020

Interventions for preventing oral candidiasis for patients with cancer receiving treatment

1 reference

12 December 2020

Oral candidosis in patients with advanced cancer

1 reference

12 December 2020

Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study

1 reference

12 December 2020

Management of oral and gastrointestinal mucositis: ESMO clinical recommendations

1 reference

12 December 2020

Oral disease in terminally ill cancer patients with xerostomia

1 reference

12 December 2020

Dental caries experience of children in remission from acute lymphoblastic leukaemia in relation to the duration of treatment and the period of time in remission

1 reference

12 December 2020

Interventions for treating oral candidiasis for patients with cancer receiving treatment

1 reference

12 December 2020

10.1007/S00520-011-1154-4

Identifiers

DOI

1 reference

24 August 2017

1 reference